Related Experiment Videos
Purulent meningitis caused by Actinomyces successfully treated with rifampicin: a case report
Keiko Imamura1, Hideki Kamitani, Hiroyuki Nakayasu
1Department of Neurology, Tottori Prefectural Central Hospital, Japan. imamurakeiko@nifty.com
Abstract:
A 64-year-old woman presented with fever and headache. Lumbar puncture revealed cerebrospinal fluid (CSF) that contained 67,386 /mm(3) of WBC; CSF culture revealed Actinomyces species. She was diagnosed with purulent meningitis caused by actinomyces, and treated with intravenous ampicillin 12 g/day. The administration of ampicillin was effective, but not sufficient to control the inflammation in CSF. CSF inflammation persisted and a gradual increase in granulation tissue was found in the subdural space on lumbar MRI. After administration of rifampicin 450 mg/day, the CSF was normalized and the enhancement of granulation tissue decreased. The patient completely recovered 5 months after the therapy was initiated. We suggest that rifampicin may be an option for the treatment of meningitis caused by actinomyces.
Insights
A case of Actinomyces meningitis in a woman was treated with ampicillin and rifampicin. Rifampicin addition resolved persistent inflammation and granulation tissue, leading to complete recovery.
Area of Science:
- Neurology
- Infectious Diseases
- Microbiology
Background:
- Actinomyces species are rare causes of meningitis, often presenting with non-specific symptoms like fever and headache.
- Purulent meningitis due to Actinomyces requires effective antimicrobial therapy to prevent severe neurological sequelae.
Observation:
- A 64-year-old woman presented with fever and headache, and cerebrospinal fluid (CSF) analysis revealed a high white blood cell (WBC) count and Actinomyces species.
- Initial treatment with intravenous ampicillin controlled the infection but not the persistent CSF inflammation and subdural granulation tissue observed on MRI.
Findings:
- Addition of rifampicin to ampicillin therapy led to normalization of CSF parameters.
- A decrease in subdural granulation tissue enhancement was noted on lumbar MRI after rifampicin administration.
- The patient achieved complete recovery 5 months after initiating combination therapy.
Implications:
- Rifampicin may be a valuable adjunctive agent in treating meningitis caused by Actinomyces.
- This case highlights the importance of considering Actinomyces in the differential diagnosis of purulent meningitis.
- Further research is warranted to establish optimal treatment regimens for Actinomyces meningitis.
Related Concept Videos
Rocky Mountain Spotted Fever
Bacterial Meningitis I: Introduction
Bacterial Meningitis
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Cryptococcal Meningitis
Atypical Pneumonia